Kytopen Corp
Develops non-viral, continuous flow cellular engineering technologies for cell therapy manufacturing
UndisclosedSeries B
Role not disclosedTH
Telegraph Hill Partners
Activity from announced rounds
Activity in this selectionUnited States · Apr 30, 2026 · Apr 1, 2026
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share